Search - tctmd.com

Displaying 1 - 14 of 14

Sort: Relevancy | Date

News Daily News

Rising HF Burden in the US Potentially Related to Changes in Cardiometabolic Factors

Yael L. Maxwell

December 02, 2025

News Daily News

NT-proBNP Cutoffs for HFpEF Diagnosis May Need Tweaking

Todd Neale

January 29, 2025

News Daily News

PREVENT Tool Accurately Predicts HF Risk, With ‘Strong’ ASCVD Overlap

Yael L. Maxwell

December 17, 2024

News Daily News

FINEARTS-HF Analysis Supports Finerenone’s Value in HFpEF With Obesity

L.A. McKeown

December 13, 2024

News Daily News

Subcutaneous Furosemide Enables HF Patients to Address Congestion at Home

Caitlin E. Cox

September 16, 2024

News Daily News

Semaglutide Has Similar Benefits in Women and Men With HFpEF

Todd Neale

June 26, 2024

News Daily News

Study Debunks Obesity Paradox in HF, Encourages BMI Alternatives

L.A. McKeown

March 24, 2023

News Daily News

Guideline-Directed Therapies Underused in Frail HF Patients

L.A. McKeown

March 11, 2022

News Daily News

Belly Fat the Biggest Driver of Obesity-Related CVD, Says AHA

Michael O'Riordan

April 26, 2021

News Daily News

High Glycemic Index Diets Linked to CVD and Mortality

Michael O'Riordan

February 24, 2021

News Daily News

Younger Type 2 Diabetes Patients Face Higher Mortality and CVD Risks

Michael O'Riordan

April 10, 2019

News Daily News

Obesity Robs People of CVD-Free Years and Ups the Risk of Dying Young

Michael O'Riordan

March 02, 2018

News Daily News

‘Obesity Paradox’ Is Alive and Well Across Racial/Ethnic Spectrum of Heart Failure Patients

Yael L. Maxwell

February 13, 2018

News Daily News

Surviving CVD: Obesity Offers No Protection for Those With New Onset Cardiac Events

Michael O'Riordan

December 07, 2017

Advertisement

Rising HF Burden in the US Potentially Related to Changes in Cardiometabolic Factors

NT-proBNP Cutoffs for HFpEF Diagnosis May Need Tweaking

PREVENT Tool Accurately Predicts HF Risk, With ‘Strong’ ASCVD Overlap

FINEARTS-HF Analysis Supports Finerenone’s Value in HFpEF With Obesity

Subcutaneous Furosemide Enables HF Patients to Address Congestion at Home

Semaglutide Has Similar Benefits in Women and Men With HFpEF

Study Debunks Obesity Paradox in HF, Encourages BMI Alternatives

Guideline-Directed Therapies Underused in Frail HF Patients

Belly Fat the Biggest Driver of Obesity-Related CVD, Says AHA

High Glycemic Index Diets Linked to CVD and Mortality

Younger Type 2 Diabetes Patients Face Higher Mortality and CVD Risks

Obesity Robs People of CVD-Free Years and Ups the Risk of Dying Young

‘Obesity Paradox’ Is Alive and Well Across Racial/Ethnic Spectrum of Heart Failure Patients

Surviving CVD: Obesity Offers No Protection for Those With New Onset Cardiac Events

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content